March 7th 2024
It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Up to half of patients infected with SARS-CoV-2 may experience symptoms lasting beyond three months post-infection, including severe fatigue, organ system-based symptoms and other persistent symptoms.
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More
Virtual Urgent Care's Slight Impact on Emergency Visits During the COVID-19 Pandemic
November 7th 2023A recent study revealed that virtual urgent care (VUC) had minimal impact on emergency department visits or hospital admissions in Ontario, Canada, during the COVID-19 pandemic. However, a significant number of study participants who initially sought virtual urgent care eventually attended an emergency department in person.
Read More
The risk of stroke is not as likely for adults 65 years and above who have taken the Pfizer-BioNTech and Moderna COVID-19 bivalent vaccines. However, there may be an elevated risk of stroke when COVID boosters are paired with high-dose flu vaccines, particularly in adults 85-years-old and above.
Read More
Prevalence of COVID-19 and Transmission Between Childcare Centers, Households is Low, Study Finds
October 26th 2023Authors of a recent JAMA Network Open study expressed there have been few reported COVID surveillance studies of childcare centers and none in the U.S. Authors stress that it's essential for policymakers to understand the real risk of COVID spread in CCCs and households so they can apply suitable mitigation measures if there were to be another surge or new variants to come about.
Read More
The Latest on Long COVID — Most Prevalent Symptoms to Research Underway | IDWeek 2023
October 12th 2023At this year’s ID Week conference in Boston, Igho Ofotokun, MD, MSc, FIDSA, Grady Distinguished Professor of Medicine at the Emory University School of Medicine, shared the latest data that COVID-19 research team, RECOVER, has gathered on Long COVID and its symptoms.
Read More
HHS Grants $45 Million to Long COVID Clinics to Transform Healthcare for Underserved Populations
September 21st 2023There are nine grant awards of $1 million each for up to 5 years — totaling to overall $45 million in grants — that would mainly support underserved, rural, vulnerable, and minority populations that are disproportionately impacted by the effects of Long COVID
Read More
Long COVID Clinical Trial Launches Under NIH, Enrollment Open
August 13th 2023This clinical trial is a part of the NIH's Researching COVID to Enhance Recovery (RECOVER) Initiative, aimed at understanding, treating and ultimately preventing the symptoms experienced by individuals following SARS-CoV-2 infection.
Read More
Nose Picking Raises Concern: Healthcare Workers at Higher Risk for COVID-19 Transmission
August 8th 2023Study results showed no significant association between those who bite their nails and SARS-CoV-2 infection, in addition to a lower rate of infection for those who wear glasses compared to those who don’t wear glasses.
Read More
COVID-19 Wastewater Metrics Matched Clinical Case Counts in Early 2022
August 2nd 2023In a study conducted from January to September 2022, 268 United States counties within 22 states participated in the U.S. Centers for Disease Control and Prevention’s National Wastewater Surveillance System (NWSS).
Read More
US ICUs Experienced ‘Load Imbalance’ During Pandemic
July 13th 2023To decrease hospital strain and overloaded capacity, and support those groups who are affected, researchers suggest the need for enhanced efforts at the regional and state levels to coordinate transfers and balance load across hospitals.
Read More
Paxlovid Shows No Benefit in Younger, Vaccinated, Healthy Adults, Study Finds
July 7th 2023Results reported in the journal Clinical Infectious Diseases did show protection against serious outcomes (emergency room visits, hospitalizations,death) among adults,18-50, with cancer and cardiovascular diseases but no such benefit among those without those diseases. The study also showed no Paxlovid benefit among those with asthma and chronic obstructive pulmonary disorder.
Read More
Long COVID Symptom Similar to That of the Flu, Sepsis
July 7th 2023In this population-based cohort study, researchers compared the risks of incident cardiovascular, neurological, and mental health conditions and rheumatoid arthritis in a year following COVID hospitalization to three different groups: pre-pandemic hospitalization for influenza, pre-pandemic hospitalization for sepsis and hospitalization for sepsis post-pandemic.
Read More
Study Shows Metformin Decreases Long COVID Rates
June 11th 2023In efforts to find the effectiveness of metformin, ivermectin and fluvoxamine, researchers of the study observed the medications in adults aged 30 to 85 years who were overweight or obese and had been diagnosed with COVID-19 within the last three days.
Read More
Some Years of Progress in Narrowing Black-White Mortality Differences. Then COVID-19 Happened
May 17th 2023Results reported in JAMA comparing Black and White populations show a narrowing and then leveling off of excess mortality and potential years of life lost before the difference widened again in 2020.
Read More
Mortality Rate for COVID-19 Patients With a Malignant Neoplasm May Be Higher in Women Than Men
May 9th 2023Researchers of a study examined the gender-specific COVID-19 case fatality risks among patients with a malignant neoplasm during hospital admissions as there is little data available for gender-specific COVID-19 mortality.
Read More
Public Schools and Ventilation Strategies That Could Reduce COVID-19 Transmission
April 7th 2023Survey results published in today's Morbidity and Mortality Weekly Report show ventilation strategies were not reported by more than 51% of school districts. Of those that reported, low-tech and inexpensive continuous airflow, which can involve opening windows and using fans, was most popular.
Read More